Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Cerebrovascular Diseases(Electronic Edition) ›› 2022, Vol. 16 ›› Issue (05): 356-359. doi: 10.11817/j.issn.1673-9248.2022.05.013

• Review • Previous Articles     Next Articles

Research progress in diagnosis and treatment of cardiomyopathy-related ischemic stroke

Ying Li1, Xueliang Qi2, Liqun Feng1, Tong Liu3, Guangzhi Liu1,()   

  1. 1. Department of Neurology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100092, China
    2. Department of Neurology, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, China
    3. Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100092, China
  • Received:2021-12-29 Online:2022-10-01 Published:2022-11-07
  • Contact: Guangzhi Liu

Abstract:

The cardiomyopathy can be divided into hypertrophic cardiomyopathy (familial, non-familial), dilated cardiomyopathy (familial, non-familial), restrictive cardiomyopathy (familial, non-familial), arrhythmogenic right ventricular cardiomyopathy, and unclassified cardiomyopathy (including left ventricular noncompaction and Takotsubo cardiomyopathy). For the cardiomyopathy-associated ischemic stroke patients, risk factors of stroke, treatment timing, and the course vary substantially. This article reviews the clinical characteristics, incidence, risk factors for embolism in various cardiomyopathies to guide the treatment of the related ischemic stroke.

Key words: Cardiomyopathy, Ischemic stroke, Embolism

京ICP 备07035254号-20
Copyright © Chinese Journal of Cerebrovascular Diseases(Electronic Edition), All Rights Reserved.
Tel: 01082266456, 15611963912, 15611963911 E-mail: zhnxgbzzbysy@163.com
Powered by Beijing Magtech Co. Ltd